Genetic Risk Profiles for Cancer Susceptibility and Therapy Response (original) (raw)

References

• Alberola V, Sarries C, Rosell R, Taron M, de las Peñas R, Camps C, Massuti B, Insa A, Garcia-Gomez R, Isla D, Artal A, Muñoz MA, Cobo M, Bover I, Gonzalez-Larriba JL, Terrasa J, Almenar D, Barcelo R, Diz P, Sanchez-Ronco M, Sanchez JJ (2004) Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer. Clin Lung Cancer 5:360–365
  Article PubMed CAS Google Scholar
• Andreassen CN, Alsner J, Overgaard J (2002) Does variability in normal tissue reactions after radiotherapy have a genetic basis — where and how to look for it? Radiother Oncol 64:131–140
  Article PubMed Google Scholar
• Bartsch H, Hietanen E (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect 104:569–577
  Article PubMed CAS Google Scholar
• Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874–897
  Article PubMed CAS Google Scholar
• Berwick M, Vineis P (2005) Measuring DNA repair capacity: small steps. J Natl Cancer Inst 97:84–85
  PubMed Google Scholar
• Brambilla E, Brambilla C, Lanhiejoul S (2005) Impact of molecular pathology on the clinical management of lung cancer. Respiration 72:229–232
  Article PubMed Google Scholar
• Bürkle A (2001) Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett 163:1–5
  Article PubMed Google Scholar
• Bürkle A (2005) Poly(ADP-ribose). The most elaborate metabolite of NAD+. FEBS J 272:4576–4589
  Article PubMed CAS Google Scholar
• Burnet NG, Johansen J, Turesson I, Nyman J, Peacock JH (1998) Describing patients’ normal tissue reactions: concerning the possibility of individualizing radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Int J Cancer 79:606–613
  Article PubMed CAS Google Scholar
• Butkiewicz D, Popanda O, Risch A, Edler L, Dienemann H, Schulz V, Kayser K, Drings P, Bartsch H, Schmezer P (2004) Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Cancer Epidemiol Biomarkers Prev 13:2242–2246
  PubMed CAS Google Scholar
• Candelaria M, Taja-Chayeb L, Arce-Salinas C, Vidal-Millan S, Serrano-Olvera A, Duenas-Gonzalez A (2005) Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives. Anticancer Drugs 16:923–933
  Article PubMed CAS Google Scholar
• Chang-Claude J, Popanda O, Tan X-L, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB (2005) Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11:4802–4809
  Article PubMed CAS Google Scholar
• Dally H, Gassner K, Jäger B, Schmezer P, Spiegelhalder B, Edler L, Drings P, Dienemann H, Schulz V, Kayser K, Bartsch H, Risch A (2002) Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO-463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer 102:530–535
  Article PubMed CAS Google Scholar
• Dally H, Bartsch H, Risch A (2003a). Correspondence re: Feyler et al., Point: myeloperoxidase (-463)G → A polymorphism and lung cancer risk. Cancer Epidemiol Biomark Prev 11:1550–1554, 2002, and Xu et al., Counterpoint: The myeloperoxidase (463)G → A polymorphism does not decrease lung cancer susceptibility in Caucasians. 11: I555–1559, 2002. Cancer Epidemiol Biomarkers Prev 12:683
  Google Scholar
• Dally H, Edler L, Jäger B, Schmezer P, Spiegelhalder B, Drings P, Dienemann H, Schulz V, Kayser K, Bartsch H, Risch A (2003b) The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. Pharmacogenetics 13:607–618
  Article PubMed CAS Google Scholar
• Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML (2000) Gender differences in genetic susceptibility for lung cancer. Lung Cancer 30:153–160
  Article PubMed CAS Google Scholar
• Efferth T, Volm M (2005) Pharmacogenetics for individualized cancer chemotherapy. Pharmacol Ther 107:155–176
  Article PubMed CAS Google Scholar
• Eichelbaum M, Ingelman-Sundberg M, Evans WE (2006) Pharmacogenomics and individualized drug therapy. Annu Rev Med 57:119–137
  Article PubMed CAS Google Scholar
• Evans WE, Relling MV (2004) Moving towards individualized medicine with pharmacogenomics. Nature 429:464–468
  Article PubMed CAS Google Scholar
• Fijneman RJA (2005) Genetic predisposition to sporadic cancer: how to handle major effects of minor genes? Cellular Oncology 27:281–292
  PubMed CAS Google Scholar
• Fischer JR, Lahm H (2004) Validation of molecular and immunological factors with predictive importance in lung cancer. Lung Cancer 45:S5151–S1617
  Article Google Scholar
• Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Daniel Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC (2006) Cyclin Dl (CCND1) A870G gene polymorphism modulates smokinginduced lung cancer risk and response to platinumbased chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung Cancer 51:303–311
  Article PubMed Google Scholar
• Grattendick K, Stuart R, Roberts E, Lincoln J, Lefkowitz SS, Bollen A, Moguilevsky N, Friedman H, Lefkowitz DL (2002) Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation. Am J Respir Cell Mol Biol 26:716–722
  PubMed CAS Google Scholar
• Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366–374
  Article PubMed CAS Google Scholar
• Hu JJ, Roush GC, Dubin N, Berwick M, Roses DF, Harris MN (1997) Poly(ADP-ribose) polymerase in human breast cancer: a case-control analysis. Pharmacogenetics 7:309–316
  Article PubMed CAS Google Scholar
• Huang Z, Guengerich FP, Kaminsky LS (1998) 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5. Carcinogenesis 19:867–872
  Article PubMed CAS Google Scholar
• Hümmerich J, Werle-Schneider G, Popanda O, Celebi O, Chang-Claude J, Kropp S, Mayer C, Debus J, Bartsch H, Schmezer P (2006) Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radiosensitivity: a pilot study in prostate cancer patients receiving radiotherapy Int J Radiat Biol 82:593–604
  Article PubMed CAS Google Scholar
• Iwakawa M, Goto M, Noda S, Sagara M, Yamada S, Yamamoto N, Kawakami Y, Matsui Y, Miyazawa Y, Yamazaki H, Tsuji H, Ohno T (2005) DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers. Mutat Res 588:1–6
  PubMed CAS Google Scholar
• Jassem J (1999) Chemotherapy of advanced non-small cell lung cancer. Ann Oncol 10[Suppl 6]:77–82
  Article PubMed Google Scholar
• Kayser K (1992) Analytical lung pathology. Springer, Berlin Heidelberg New York
  Google Scholar
• Larsen JE, Colosimo ML, Yang LA, Bowman R, Zimmerman PV, Fong KM (2006) CYP1A1 I1e462Va1 and MPO G-46 3A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 27:525–532
  Article PubMed CAS Google Scholar
• Lee W, Lockhart AC, Kim RB, Rothenberg ML (2005) Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. Oncologist 10:104–111
  Article PubMed CAS Google Scholar
• Lipshutz R (2005) Using microarrays to detect disease and tailor therapy. Pharmaceut Discov 5:28–37
  CAS Google Scholar
• Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64:6344–6348
  Article PubMed CAS Google Scholar
• Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia S, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P, Palli D (2003) Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a populationbased study. Cancer Epidemiol Biomarkers Prev 12:674–677
  PubMed CAS Google Scholar
• Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, Law J, Berntsen T, Chadha H, Hui H, Yang G, Kennedy GC, Webster TA, Cawley S, Walsh PS, Jones KW, Fodor SP, Mei R (2004) Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 1:109–111
  Article PubMed CAS Google Scholar
• Mayer C, Popanda O, Zelezny O, von Brevern M-C, Bach A, Bartsch H, Schmezer P (2002) DNA repair capacity after gamma-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes. DNA Repair (Amst) 1:237–250
  Article CAS Google Scholar
• Mayne ST, Buenconsejo J, Janerich DT (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149:13–20
  PubMed CAS Google Scholar
• Mohrenweiser HW, Wilson DM III, Jones IM (2003) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 526:93–125
  PubMed CAS Google Scholar
• Muscat JE, Wynder EL (1995) Lung cancer pathology in smokers, ex-smokers and never smokers. Cancer Lett 88:1–5
  Article PubMed CAS Google Scholar
• Nebert DW, Vesell ES (2004) Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. Eur J Pharmacol 500:267–280
  Article PubMed CAS Google Scholar
• Pauk N, Kubik A, Zatloukal P, Krepela E (2005) Lung cancer in women. Lung Cancer 18:1–9
  Article Google Scholar
• Peters L, McKay M (2001) Predictive assays: will they ever have a role in the clinic? Int J Radiat Oncol Biol Phys 49:501–504
  Article PubMed CAS Google Scholar
• Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, Thielmann HW, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Bartsch H, Chang-Claude J (2003) Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys 55:1216–1225
  Article PubMed Google Scholar
• Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25:2433–2441
  Article PubMed CAS Google Scholar
• Rajaee-Behbahani N, Schmezer P, Risch A, Rittgen W, Kayser KW, Dienemann H, Schulz V, Drings P, Thiel S, Bartsch H (2001) Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer 95:86–91
  Article PubMed CAS Google Scholar
• Rajaee-Behbahani N, Schmezer P, Ramroth H, Bürkle A, Bartsch H, Dietz A, Becher H (2002) Reduced poly(ADP-ribosyl)ation in lymphocytes of laryngeal cancer patients: results of a case-control study. Int J Cancer 98:780–784
  Article PubMed CAS Google Scholar
• Raunio H, Hakkola J, Pelkonen O (2005) Regulation of CYP3A genes in the human respiratory tract. Chem Biol Interact 151:53–62
  Article PubMed CAS Google Scholar
• Relling MV, Dervieux T (2001) Pharmacogenetics and cancer therapy. Nat Rev Cancer 1:99–108
  Article PubMed CAS Google Scholar
• Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93:2817–2823
  PubMed CAS Google Scholar
• Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB (1993) Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 138:281–293
  PubMed CAS Google Scholar
• Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B, Bartsch H (2001) Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 11:757–764
  Article PubMed CAS Google Scholar
• Rosell R, Taron M, Ariza A, Barnadas A, Mate JL, Reguart N, Margel M, Felip E, Mendez P, Garcia-Campelo R (2004) Molecular predictors of response to chemotherapy in lung cancer. Semin Oncol 31:20–27
  Article PubMed CAS Google Scholar
• Schmezer P, Rajaee-Behbahani N, Risch A, Thiel S, Rittgen W, Drings P, Dienemann H, Kayser KW, Schulz V, Bartsch H (2001) Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis 16:25–30
  Article PubMed CAS Google Scholar
• Schunck C, Johannes T, Varga D, Lorch T, Plesch A (2004) New developments in automated cytogenetic imaging: unattended scoring of dicentric chromosomes, micronuclei, single cell gel electrophoresis, and fluorescence signals. Cytogenet Genome Res 104:383–389
  Article PubMed CAS Google Scholar
• Scripture CD, Sparreboom A, Figg WD (2005) Modulation of cytochrome P450 activity: implications for cancer therapy. Lancet Oncol 6:780–789
  Article PubMed CAS Google Scholar
• Spitz MR, Wei Q, Dong Q, Amos CI, Wu X (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12:689–698
  PubMed CAS Google Scholar
• Spitz MR, Wu X, Mills G (2005) Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol 23:267–275
  Article PubMed Google Scholar
• Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Foumier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2005) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97:255–262
  Article PubMed CAS Google Scholar
• Thomas M, Baumann M, Deppermann M, Freitag L, Gatzemeier U, Huber R, Passlick B, Serke M, Ukena D (2002) Recommendations on the therapy of bronchial carcinoma. Pneumologie 56:113–131
  Article PubMed CAS Google Scholar
• Toyooka S, Tokumo M, Shigematsu H, Matsuo K, Asano H, Tomii K, Ichihara S, Suzuki M, Aoe M, Date H, Gazdar AF, Shimizu N (2006) Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 66:1371–1375
  Article PubMed CAS Google Scholar
• Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2003) Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol 69:145–153
  Article PubMed CAS Google Scholar
• US NIH Cancer Therapy Evaluation Program (1999) Common Toxicity Criteria; Available from: http://ctep.cancer.gov/reporting/ctc.html. Cited 4 August 2006
  Google Scholar
• Villafranca E, Okruzhnov Y, Dominguez MA, Garcia-Foncillas J, Azinovic L, Martinez E, Illarramendi JJ, Arias F, Martinez MR, Salgado E, Angeletti S, Brugarolas A (2001) Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol 19:1779–1786
  PubMed CAS Google Scholar
• Vineis P (2004) Individual susceptibility to carcinogens. Oncogene 23:6477–6483
  Article PubMed CAS Google Scholar
• Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G, Tannenbaum SR (1994) Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369:154–156
  Article PubMed CAS Google Scholar
• Wikman H, Thiel S, Jäger B, Schmezer P, Spiegelhalder B, Edler L, Dienemann H, Kayser K, Schulz V, Drings P, Bartsch H, Risch A (2001) Relevance of N-acetyltransferases 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics 11:157–168
  Article PubMed CAS Google Scholar
• Wild CP (2005) Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14:1847–1850
  Article PubMed CAS Google Scholar
• Zochbauer-Muller S, Pirker R, Huber H (1999) Treatment of small cell lung cancer patients. Ann Oncol 10[Suppl 6]:83–91
  Article PubMed Google Scholar

Download references